Amiotrófiás laterálszklerózis (ALS): vizsgálatok itt: Kína
21 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in KínaEndovascular Brain-Computer Interface for Upper-Limb Paralysis
- Where
- Nanjing
- Életkor
- 20 év to 75 év
- People
- 2
- Run by
- Wei Wu
See details and how to joinNCT07934914 - 1/2. fázisTaking peopleTP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 60
- Run by
- Talengen Institute of Life Sciences, Shenzhen, P.R. China.
See details and how to joinNCT06726577 - 2/3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 240
- Run by
- Shanghai Zhimeng Biopharma, Inc.
See details and how to joinNCT07082192 - 2. fázisNot yet taking people in KínaA Phase II Study of ALT001 in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 150
- Run by
- Darwin Origin (Hubei) Biopharmaceutical Co., Ltd.
See details and how to joinNCT07833618 - No phaseCsak meghívásosUnrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
- Where
- Tianjin
- Életkor
- 35 év to 50 év
- People
- 8
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07539662 - 1. fázisTaking peopleThe Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 12
- Run by
- XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
See details and how to joinNCT07118319 - 1. fázisTaking peopleClinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases
- Where
- Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 12
- Run by
- Novabio Therapeutics
See details and how to joinNCT06671236 - 1/2. fázisNot yet taking people in KínaA Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS
- Where
- Beijing, Fuzhou, Hangzhou
- Életkor
- 18 év to 80 év
- People
- 21 worldwide
- Run by
- SineuGene Therapeutics Co., Ltd.
See details and how to joinNCT07169175 - 1. fázisNot yet taking people in KínahUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 120
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT06607900 - No phaseTaking peopleThe Study Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Powder Among Patients With Motor Neuron Disease
- Where
- Hangzhou
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- First People's Hospital of Hangzhou
See details and how to joinNCT06765499 - Korai 1. fázisTaking peopleA Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 6
- Run by
- Hong Chen
See details and how to joinNCT06849609 - No phaseTaking peopleResearch on Wireless Brain Implant System for General Control of External Devices
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 4
- Run by
- Shanghai StairMed Technology Co., Ltd.
See details and how to joinNCT06829212 - No phaseTaking peopleClinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)
- Where
- Shanghai
- Életkor
- 18 év to 60 év
- People
- 3
- Run by
- Shanghai East Hospital
See details and how to joinNCT06765564 - 1. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation
- Where
- Beijing, Chengdu, Hangzhou
- Életkor
- 18 év and over
- People
- 32
- Run by
- Ractigen Therapeutics.
See details and how to joinNCT06556394 - Korai 1. fázisNot yet taking people in KínaTofacitinib in Patients With Amyotrophic Lateral Sclerosis
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 12
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT06689982 - Korai 1. fázisNot yet taking people in KínaAn IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis
- Where
- Beijing, Chengdu, Fujian, Hangzhou, Nanjing
- Életkor
- 18 év to 80 év
- People
- 7
- Run by
- Peking University Third Hospital
See details and how to joinNCT06645197 - 4. fázisTaking peopleClinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 64
- Run by
- Peking University Third Hospital
See details and how to joinNCT05923905 - No phaseCsak meghívásosExplore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 2500
- Run by
- Peking University Third Hospital
See details and how to joinNCT04961450 - No phaseTaking peopleChina Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 2000
- Run by
- Dongzhimen Hospital, Beijing
See details and how to joinNCT04885374 - No phaseTaking peopleA Registered Cohort Study on Amyotrophic Lateral Sclerosis
- Where
- Fuzhou
- People
- 2000
- Run by
- First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT04008329 - No phaseTaking peopleNatural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
- Where
- Beijing
- People
- 3000
- Run by
- Peking University Third Hospital
See details and how to joinNCT04454892